Moreover, recent studies have indicated that GLP1 medications may have cardiovascular benefits, further enhancing their appeal in the management of type 2 diabetes
Not according to this article
Mild water retention occurs in a significant percentage of users
M.SchwartzS
Amylin accelerates the onset of fullness
doi: 10.3389/fendo.2025.1624001 Received 06 May 2025 Accepted 17 June 2025 Published 04 July 2025 Volume 16 - 2025 Edited by Valeria Guglielmi, Policlinico Tor Vergata, Italy Reviewed by Ilaria Milani, Sapienza University of Rome, Italy Jenny Pena Dias, Johns Hopkins University, United States Updates Copyright 2025 Andrade, Lobato, Machado, Hartmann, Holst, Almeida, Nora, Monteiro, Guimares and Pereira